Aplagon
  • ABOUT US
    • Management Team
    • Scientific Advisory Board
    • Investors
  • PRODUCTS
  • PARTNERING
  • NEWS & EVENTS
    • Publications
  • CONTACT US
  • Menu

Latest news

  • Bio-Europe 202113th November 2019
  • Aplagon Granted Patent for Therapeutic Anti-Platelet and Anti-Coagulant Molecule In Europe and South Africa14th November 2018
  • Aplagon Partners with Cadila Pharmaceuticals to Develop and Commercialize APAC First-in-Class Antithrombotics for the Prevention of Blood Vessel Occlusions Related to Vascular Interventions19th September 2017

Website by Instinctif Partners

Aplagon Oy
Biomedicum Helsinki 2A
Tukholmankatu 8 A, 00290 Helsinki, Finland

Scroll to top